Biofouling is a ubiquitous problem in many places in society and technology, especially in reverse osmosis or nanofiltration (NF) processes. Initial stages in the development of the biofilm include attachment of bacteria to the surface, where bacterial outer membrane components such as biopolymers, lipids, and proteins play important roles. Here we show that the glycosphingolipid (GSL) unique to Sphingomonas species is a key player in the initial attachment of bacteria to NF membranes whereas lipopolysaccharide (LPS), the major glycolipid in many Gram-negative species, is less significant. GSL and LPS were deposited on an NF membrane with subsequent bacterial culture injection in a three-dimensionally printed microfluidic flow cell. Flux, rejection, and pressure changes showed that GSL caused permanent membrane fouling. This study underlines the significance of Sphingomonas for the initial attachment of bacteria to membranes. A deeper understanding and identification of key components in the biofouling process may help define strategies for biofilm prevention.
Understanding and restricting microbial surface attachment will enhance wastewater treatment with membranes. We report a maskless lithographic patterning technique for the generation of patterned polymer coatings on ultrafiltration membranes. Polyethylene glycol, zwitterionic, or negatively charged hydrophilic polymer compositions in parallel- or perpendicular-striped patterns with respect to feed flow were evaluated using wastewater. Membrane fouling was dependent on the orientation and chemical composition of the coatings. Modifications reduced alpha diversity in the attached microbial community (Shannon indices decreased from 2.63 to 1.89) which nevertheless increased with filtration time. Sphingomonas species, which condition membrane surfaces and facilitate cellular adhesion, were depleted in all modified membranes. Microbial community structure was significantly different between control, different patterns, and different chemistries. This study broadens the tools for surface modification of membranes with polymer coatings and for understanding and optimization of antifouling surfaces.
Minimization and management of membrane fouling is a formidable challenge in diverse industrial processes and other practices that utilize membrane technology. Understanding the fouling process could lead to optimization and higher efficiency of membrane based filtration. Here we show the design and fabrication of an automated three-dimensionally (3-D) printed microfluidic cross-flow filtration system that can test up to 4 membranes in parallel. The microfluidic cells were printed using multi-material photopolymer 3-D printing technology, which used a transparent hard polymer for the microfluidic cell body and incorporated a thin rubber-like polymer layer, which prevents leakages during operation. The performance of ultrafiltration (UF), and nanofiltration (NF) membranes were tested and membrane fouling could be observed with a model foulant bovine serum albumin (BSA). Feed solutions containing BSA showed flux decline of the membrane. This protocol may be extended to measure fouling or biofouling with many other organic, inorganic or microbial containing solutions. The microfluidic design is especially advantageous for testing materials that are costly or only available in small quantities, for example polysaccharides, proteins, or lipids due to the small surface area of the membrane being tested. This modular system may also be easily expanded for high throughput testing of membranes.
Video LinkThe video component of this article can be found at
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.